In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates

American Journal of Hematology

Volumn 82, Issue 6, 2007, Pages 460-462

  Tagariello, Giuseppe ^a   Zanotto, Daniela ^a   Radossi, Paolo ^a   Sartori, Roberto ^a   Belvini, Donata ^a   Salviato, Roberta ^a  

^a Castelfranco Veneto Hospital   (Italy)

Author keywords

Factor VIII inhibitors; Hemophilia A; Von Willebrand factor

Indexed keywords

BERIATE P; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 8; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANTIGENICITY; ARTICLE; CHILD; CLINICAL FEATURE; DRUG EFFECT; HEMOPHILIA A; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL PRODUCTS; BLOOD COAGULATION FACTOR INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; HEMOPHILIA A; HUMANS; INFANT; MIDDLE AGED; MUTATION; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 34249786574     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20863     Document Type: Article

References (8)

1. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: A systematic review. Haemophilia 2003;9:418-435.
2. Wise RJ, Dorner AJ, Krane M, Pittman DD, Kaufman RJ. The role of von Willebrand Factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 1991;15:21948-21955.
3. Gensana M, Altisent C, Aznar JA, et al. Influence of vWF on the reactivity of human factor VIII inhibitors with factor VIII. Haemophilia 2001;7:369-374.
4. Kasper CK, Aledort L, Aronson D, et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:612.
5. Amano K, Arai M, Koshihara K, et al. Autoantibody to factor VIII that has less reactivity to factor VIII/von Willebrand factor complex. Am J Hematol 1995;49:310-317.
6. Sukhu K, Keeling DM, Giangrande PL. Variation in inhibitor reactivity in acquired haemophilia A with different concentrates. Clin Lab Haematol 2000;22:287-290.
7. Suzuki T, Arai M, Amano K, Kagawa K, Fukutake K. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor. Thromb Haemost 1996;76:749-754.
8. Kallas A, Talpsep T. von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients. Haemophilia 2001;7:375-380.